GW Pharmaceuticals PLC- ADR (GWPH) Stock Declines -0.34% This Week; Should You Buy It?

Monday, April 6, 2020 3:13 PM | InvestorsObserver Analysts

GW Pharmaceuticals PLC- ADR (GWPH) stock has fallen -49.33% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives GWPH stock a score of 57 out of a possible 100.

That rank is primarily influenced by a fundamental score of 70. In addition to the average rating from Wall Street analysts, GWPH stock has a mean target price of 188.428. This means analysts expect the stock to climb 121.97% over the next 12 months. GWPH's rank also includes a long-term technical score of 68. The short-term technical score for GWPH is 33.

Overall Score - 57
GWPH has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on GWPH!

What's Happening with GWPH Stock Today

GW Pharmaceuticals PLC- ADR (GWPH) stock has risen 3.78% while the S&P 500 is higher by 5.66% as of 3:10 PM on Monday, Apr 6. GWPH is higher by $3.09 from the previous closing price of $81.80 on volume of 466,018 shares. Over the past year the S&P 500 is down -9.20% while GWPH has fallen -49.33%. GWPH lost -$0.29 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on GW Pharmaceuticals PLC- ADR (GWPH) Stock.

Share this article:

Related Companies

You May Also Like

Related Articles

Sector Update: Health Care Stocks Fading Near Tuesday Bell

Sector Update: Health Care

Pulse Biosciences Inc (PLSE) is down -8.41% in a Week, Should You Hold?

How Does iTeos Therapeutics Inc (ITOS) Stock Rank on Wall Street Tuesday?

Does Akouos Inc (AKUS) Have What it Takes to be in Your Portfolio Tuesday?

Analyst Rating: Will Arcturus Therapeutics Holdings Inc (ARCT) Stock Lead the Market?

Related Companies